These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1671 related articles for article (PubMed ID: 27195672)
41. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558 [TBL] [Abstract][Full Text] [Related]
42. lncRNA Yang J; Lin X; Jiang W; Wu J; Lin L DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568 [TBL] [Abstract][Full Text] [Related]
43. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
44. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). He R; Zhang FH; Shen N Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731 [TBL] [Abstract][Full Text] [Related]
45. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer. Luo J; Xiang H Bioengineered; 2021 Dec; 12(1):3101-3112. PubMed ID: 34181498 [TBL] [Abstract][Full Text] [Related]
46. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway. Liu C; Ren L; Deng J; Wang S Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897 [TBL] [Abstract][Full Text] [Related]
47. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis. Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871 [TBL] [Abstract][Full Text] [Related]
48. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells. Yao F; Liu H; Li Z; Zhong C; Fang W Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426 [TBL] [Abstract][Full Text] [Related]
49. Single-nucleotide polymorphism rs4142441 and MYC co-modulated long non-coding RNA OSER1-AS1 suppresses non-small cell lung cancer by sequestering ELAVL1. Xie W; Wang Y; Zhang Y; Xiang Y; Wu N; Wu L; Li C; Cai T; Ma X; Yu Z; Bai L; Li Y Cancer Sci; 2021 Jun; 112(6):2272-2286. PubMed ID: 33113263 [TBL] [Abstract][Full Text] [Related]
50. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer. Hong S; Yan Z; Song Y; Bi M; Li S Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509 [TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259 [TBL] [Abstract][Full Text] [Related]
52. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935 [TBL] [Abstract][Full Text] [Related]
53. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539 [TBL] [Abstract][Full Text] [Related]
54. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level. Chen X; Wang K Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021 [TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway. Zheng Y; Lu S; Xu Y; Zheng J Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575 [TBL] [Abstract][Full Text] [Related]
56. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
57. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer. Liu JQ; Feng YH; Zeng S; Zhong MZ Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854 [TBL] [Abstract][Full Text] [Related]
58. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling. Rong L; Zhao R; Lu J Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805 [TBL] [Abstract][Full Text] [Related]
59. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918 [TBL] [Abstract][Full Text] [Related]
60. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis. An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]